BiotechTube
Home/Braveheart Bio/Paul Rickey
PR

Paul Rickey

Chief Financial Officer

Braveheart Bio

Therapeutic Areas

CardiovascularMetabolic

Braveheart Bio Pipeline

DrugIndicationPhase
BHB-1893Hypertrophic Cardiomyopathy (Obstructive and Non-obstructive)Phase 3

Leadership Team at Braveheart Bio

TM
Travis Murdoch, M.D.
Chief Executive Officer
ED
Emil deGoma, M.D.
Chief Medical Officer
MA
Michele Anderson
Chief Development Officer
ME
Marc Evanchik, M.S.
Chief Scientific Officer
View full Braveheart Bio profile